Klotho Neurosciences, Inc. Logo

Klotho Neurosciences, Inc.

Advancing gene and cell therapies for neurodegenerative disorders, cancer, and chronic diseases.

KLTO | NDAQ

Overview

Corporate Details

ISIN(s):
US7580831094 (+2 more)
LEI:
Country:
United States of America
Address:
13576 WALNUT STREET, SUITE A, 68144 OMAHA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Klotho Neurosciences, Inc. is a biopharmaceutical company dedicated to developing disease-modifying therapies for age-related and chronic diseases. The company utilizes advanced protein, cell, and gene therapy platforms, including proprietary DNA and RNA-based therapeutics, to address areas of high unmet medical need. Its core programs target neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Klotho Neurosciences is also expanding its development pipeline to include treatments for cardiovascular diseases and cancer, often leveraging its research into the therapeutic potential of the α-Klotho protein and its biological pathways.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Klotho Neurosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Klotho Neurosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Klotho Neurosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bayer AG Logo
A life science firm providing pharmaceuticals, consumer health, and crop science solutions.
Germany BAY
Beam Therapeutics Inc. Logo
Developing precision genetic medicines using base editing to provide cures for serious diseases.
United States of America BEAM
BELITE BIO, INC Logo
Developing novel oral therapies for retinal degenerative eye diseases like GA and Stargardt disease.
United States of America BLTE
Benchmark Holdings Plc Logo
Aquaculture biotech providing nutrition and health solutions for sustainable farming.
United Kingdom BMK
Benitec Biopharma Inc. Logo
Develops ddRNAi gene therapies to silence genes causing chronic, life-threatening diseases.
United States of America BNTC
BeOne Medicines Ltd. Logo
Develops innovative and accessible cancer treatments for patients worldwide.
United States of America ONC
BGM Group Ltd. Logo
A pharma holding co. making APIs & TCM derivatives via bio-fermentation and extraction.
United States of America BGM
Bicara Therapeutics Inc. Logo
Developing first-in-class, dual-action bifunctional therapies for solid tumor patients.
United States of America BCAX
BICYCLE THERAPEUTICS PLC Logo
Developing novel bicyclic peptide medicines to precisely target hard-to-treat cancers.
United States of America BCYC
BIFIDO. Co. Ltd Logo
Biotech firm specializing in microbiome R&D for functional foods and cosmeceuticals.
South Korea 238200

Talk to a Data Expert

Have a question? We'll get back to you promptly.